Svcv) in Ontario
Total Page:16
File Type:pdf, Size:1020Kb
PATHOGENESIS AND DISTRIBUTION OF SPRING VIREMIA OF CARP VIRUS (SVCV) IN ONTARIO by Ehab Misk A Thesis Presented to The University of Guelph In partial fulfillment of requirements for the degree of Doctor of Philosophy in Pathobiology Guelph, Ontario, Canada © Ehab Misk, May 2016 ABSTRACT PATHOGENESIS AND DISTRIBUTION OF SPRING VIREMIA OF CARP VIRUS (SVCV) IN ONTARIO Ehab Misk Advisor: University of Guelph, 2016 Professor John S. Lumsden Spring viremia of carp virus (SVCV), an OIE reportable rhabdovirus and fish pathogen, was identified in Canada in 2006 in Hamilton Harbour but has not been reported subsequently. SVCV can have a significant impact on cyprinids, and so the susceptibility of three baitfish species (emerald shiner Notropis atherinoides, fathead minnow Pimpheles promelas, white sucker Catostomus commersonii from the order Cypriniformes was assessed using experimental infection. Millions of baitfish are moved around the province to support the sports fishing industry, and this represents a risk for spread of the virus. Emerald shiner, fathead minnow and koi (43, 53, and 33% mortality, respectively) were highly susceptible, but white sucker or rainbow trout (12.5 and 0% mortality), were not. Infection was confirmed by virus isolation and RT-qPCR and SVCV was immunolocalized in association with histological lesions using immunohistochemistry. A one-step reverse transcription quantitative PCR (RT-qPCR) was adapted and used retrospectively to test samples collected by the Ontario Ministry of Natural Resources for surveillance from 2008 to 2012. A total of 1432 fish from 35 water bodies in Ontario were examined using RT-qPCR, but no additional fish were identified with SVCV. Finally, the pathogenesis of the Rhabdovirus-host interaction at the gill epithelium was investigated using the RTgill-W1 cells. The cell line was pretreated with UV-inactivated (killed) VHSV and recombinant FliC and then infected with viral hemorrhagic septicemia virus (VHSV). The viral load and gene expression was investigated 1, 3, and 6 d post infection (PI) with qPCR. In addition, the transcriptome response of RTgill-W1 cells at 36 h post-treatment with SVCV, VHSV, UV-inactivated VHSV and FliC were tested using microarray and RT-qPCR. Pretreatment of RTgill-W1 cells with killed VSHV induced a reduction in viral load (nucleoprotein copy number by RT-qPCR) after infection. Transcription profiles in VHSV- and SVCV-infected or killed VHSV and FliC pretreated RTgill-W1 cells 36 h post-exposure detected 24, 22, 123 and 190 differentially expressed probes, which contained several important gene candidates with a potentially key role in innate immunity to rhabdovirus infection in gill epithelium. ACKNOWLEDGEMENTS I would like to express my sincere appreciation to my advisor Dr. John Lumsden for his unlimited high standard professional academic support, career orientation, and personal support for me throughout my Ph.D. program. I would also like to extend my gratitude to my advisory committee Dr. Eva Nagy and Dr. Kyle Graver for their marvelous contribution in shaping my work in its best form. I owe a special acknowledgment to Paul Huber his professional technical support, refinement of my protocols and troubleshooting especially with the virus purification using sucrose gradients. I would also like to acknowledge to my current graduate student colleagues, Maureen Jarau, Ryan Horricks, Doran Kirkbright, Juan-Ting Liu, Paige Vroom and Jaramar Balmori-Cedeno for their support, fruitful discussions, and maintaining social interaction. I would also like to extend my gratitude to my former graduate student colleagues Dr. Lowia Al-Hussinee, Dr. Veronique Lepage, Dr. Alex Reid, Dr. Elena Contador, and Jessica Grice for providing a supportive and collaborative environment during the experimental trials portion of my thesis. I am indebted to Mr. R. Frank and M. Cornish from the Hagan Aqualab for setting up the biosecurity room for the experimental infection trials. I would also like to extend my thanks to the administrative and technical staff members of the department: Donna Kangas, Cathy Bernardi, Karla De Uslar, Marni Struyk, and Elizabeth Gilbertson, who have been very kind and helpful in their respective roles. This thesis research would not have been possible without the financial support provided by the Egyptian Government, The Ontario Ministry of Agriculture Food and Rural Affairs, the iv Ontario Ministry of Natural Resources and the National Engineering and Research Council of Canada. Finally, and most importantly I would like to thank Fatma Misk, my wife, who gave so much love, support, trust and time for me to be able to finish my studies and to my adorable daughters who make the world a better place. v DECLARATION OF WORK PERFORMED All work reported in this thesis was performed by myself under supervision of Dr. John Lumsden and my advisory committee; Dr. Eva Nagy and Dr. Kyle Garver, with following exceptions: The polyclonal antibody to SVCV and VHSV IVb used for immunohistochemistry in Chapter 2 was prepared by Paul Huber and Dr. Alex Reid. The VHSV one step RT-qPCR for VHSV and SVCV protocols used in Chapter 2, 3 and 4 was developed by Dr. Lincoln Tubbs but adapted and optimized by myself. Steve Lord from the Fish Health Laboratory, University of Guelph, performed the SVCV isolation in Chapter 2 from experimentally infected fish. The Princess Margaret Genomics Center, University Health Network, Ontario performed the labeling and processing of the microarray chips. vi TABLE OF CONTENTS 1 LITERATURE REVIEW ............................................................................................................ 1 1.1 INTRODUCTION ................................................................................................................... 1 1.2 SVC IN THE WORLD AND NORTH AMERICA ........................................................................ 3 1.3 TAXONOMY ......................................................................................................................... 4 1.4 FISH SPECIES AND LESIONS PRODUCED ............................................................................... 6 1.5 PATHOGENESIS OF THE DISEASE ......................................................................................... 8 1.5.1 Strains of the virus .......................................................................................................... 8 1.5.2 Mechanistic basis of lesion development. ....................................................................... 9 1.5.3 Innate immunity to SVCV ............................................................................................. 10 1.5.4 Transmission................................................................................................................. 12 1.5.5 Infection temperature ................................................................................................... 12 1.6 DIAGNOSIS ........................................................................................................................ 13 1.6.1 History, clinical signs, and pathological lesions .......................................................... 13 1.6.2 Virus isolation. ............................................................................................................. 15 1.6.3 Virus identification ....................................................................................................... 16 2 PATHOGENESIS OF SPRING VIREMIA OF CARP IN EMERALD SHINER NOTROPIS ATHERINOIDES RAFINESQUE, FATHEAD MINNOW PIMEPHALES PROMELAS RAFINESQUE AND WHITE SUCKER CATOSTOMUS COMMERSONII (LACEPEDE) ............................................... 22 2.1 INTRODUCTION ................................................................................................................. 24 2.2 MATERIALS AND METHODS .............................................................................................. 25 2.2.1 Virus propagation and plaque assay ............................................................................ 25 2.2.2 Fish ............................................................................................................................... 27 2.2.3 Experimental Infection and sampling ........................................................................... 27 vii 2.2.4 Total RNA Extraction ................................................................................................... 28 2.2.5 Reverse transcription polymerase chain reaction ........................................................ 29 2.2.6 Virus Isolation .............................................................................................................. 30 2.2.7 Gross pathology, histopathology, and IHC .................................................................. 30 2.2.8 Virus purification .......................................................................................................... 31 2.2.9 Rabbit antibody ............................................................................................................ 31 2.2.10 Statistical analysis .................................................................................................... 32 2.3 RESULTS ............................................................................................................................ 33 2.3.1 Experimental trial ......................................................................................................... 33 2.3.2 Detection of SVCV by RT-qPCR